A Study to Determine the Safety and Tolerability of Herceptin as an Adjuvant Therapy of Early Breast Cancer
CompletedOBSERVATIONAL
Enrollment
211
Participants
Timeline
Start Date
July 31, 2006
Primary Completion Date
November 30, 2009
Study Completion Date
November 30, 2009
Conditions
Breast Cancer, Early Breast Cancer
Interventions
OTHER
No intervention
Trial Locations (1)
21204
Kamenitz
All Listed Sponsors
lead
Hoffmann-La Roche
INDUSTRY
NCT02443467 - A Study to Determine the Safety and Tolerability of Herceptin as an Adjuvant Therapy of Early Breast Cancer | Biotech Hunter | Biotech Hunter